Intergy Private Wealth’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$586K Buy
3,740
+343
+10% +$51.4K 0.14% 67
2026
Q1
$519K Sell
3,397
-79
-2% -$12.1K 0.15% 66
2025
Q4
$479K Buy
3,476
+135
+4% +$17.7K 0.14% 65
2025
Q3
$428K Buy
3,341
+169
+5% +$20.6K 0.13% 70
2025
Q2
$384K Buy
3,172
+415
+15% +$46.8K 0.13% 72
2025
Q1
$307K Buy
2,757
+104
+4% +$11.1K 0.12% 73
2024
Q4
$258K Buy
2,653
+154
+6% +$16.4K 0.1% 77
2024
Q3
$287K Buy
2,499
+276
+12% +$31.3K 0.11% 71
2024
Q2
$237K Buy
+2,223
New +$223K 0.1% 73
2024
Q1
Sell
-2,018
Closed -$204K 79
2023
Q4
$204K Buy
+2,018
New +$195K 0.09% 73

Other funds holding NVS

Intergy Private Wealth's NVS Position: Q2 2026 in Review

Intergy Private Wealth increased its Novartis (NVS) stake by 10% in Q2 2026, buying an estimated $51.4K and bringing the position to 3,740 shares worth $586K. The position accounts for 0.14% of the portfolio, ranked #67.

Intergy Private Wealth first reported a position in NVS in Q4 2023 and has held it in 10 quarters since. 365 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Intergy Private Wealth held 3,740 shares of Novartis worth $586K as of Q2 2026.
  • Intergy Private Wealth bought 343 Novartis shares in Q2 2026, an estimated $51.4K.
  • Novartis made up 0.14% of Intergy Private Wealth's portfolio in Q2 2026, its #67 holding.
  • Intergy Private Wealth first reported a position in Novartis in Q4 2023 and has held it in 10 quarters since.
  • 365 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Intergy Private Wealth's 13F filing for Q2 2026, filed 17 Jul 2026.